Nuzenio

Onclive Targeted Therapy

Onclive Targeted Therapy entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Dr Cohen on FcRH5 as a Therapeutic Target in Multiple Myeloma - OncLiveOncLive · Tue, 04 Aug 2026 03:17:03 GMTThe Importance of Giving the Most Effective Therapy Upfront in TNBC - OncLiveOncLive · Mon, 03 Aug 2026 14:55:00 GMTThe Future of Antibody-Drug Conjugates and Oncogene-Directed Therapy in NSCLC - OncLiveOncLive · Fri, 31 Jul 2026 12:14:27 GMTTargeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLiveOncLive · Wed, 29 Jul 2026 16:01:06 GMT

Timeline

Tue, 04 Aug 2026 03:17:03 GMTDr Cohen on FcRH5 as a Therapeutic Target in Multiple Myeloma - OncLive
Mon, 03 Aug 2026 14:55:00 GMTThe Importance of Giving the Most Effective Therapy Upfront in TNBC - OncLive
Fri, 31 Jul 2026 12:14:27 GMTThe Future of Antibody-Drug Conjugates and Oncogene-Directed Therapy in NSCLC - OncLive
Wed, 29 Jul 2026 16:01:06 GMTTargeted Therapy Expands Into Adjuvant and Neoadjuvant Settings for Oncogene-Driven Early-Stage NSCLC - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Onclive Targeted Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.